Whole blood lumiaggregation: Evaluation of reagents

Clinical and Applied Thrombosis/Hemostasis

Volumn 4, Issue 4, 1998, Pages 253-256

  Vucenik, Ivana ^a   Podczasy, John J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Agonists; Platelet aggregation; Platelets

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; COLLAGEN; REAGENT; RISTOCETIN; THROMBIN;

ADULT; ARTICLE; CONTROLLED STUDY; DILUTION; HUMAN; HUMAN EXPERIMENT; IMPEDANCE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STORAGE; TEMPERATURE; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

EID: 0031714969     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969800400407     Document Type: Article

References (15)

1. Lages B, Sussman II, Levine SP, et al. Platelet alpha granule deficiency associated with decreased P-selectin and selective impairment of thrombin-induced activation in a new patient with gray platelet syndrome (alpha-storage pool deficiency). J Lab Clin Med 1997;129:364.
2. 2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production. Thromb Haemost 1997;77:986.
3. Pearson TA, LaCava J, Weil HF. Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease. Am J Clin Nutr 1997;65:1674S.
4. Komiya T, Kudo M, Urabe T, Mizuno Y. Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease: assessment by platelet aggregation testing. Stroke 1994;25:2337.
5. Feng D, McKenna C, Murillo J, et al. Effect of aspirin dosage and enteric coating on platelet reactivity. Am J Cardiol 1997;80:189.
6. Muller TH, Weisenberger H, Brickl R, et al. Profound and sustained inhibition of platelet aggregation by Fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug. Lefradafiban, in men. Circulation 1997;96:1130.
7. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962;194:927.
8. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assisting platelet behavior in blood. J Pharm Methods 1980;3:135.
9. Mackie IJ, Jones R, Machin SJ. Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs. J Clin Pathol 1984;37:874.
10. Podczasy JJ, Lee J, Vucenik I. Evaluation of whole-blood lumi-aggregation. Clin Appl Thromb Hemost 1997;3:190.
11. Muller MR, Salat A, Pulaki S, et al. Influence of hematocrit and platelet count on impedance and reactivity of whole blood for electrical aggregometry. J Pharmacol Toxicol Methods 1995;34:17.
12. Bertolino G, Noris P, Balduini CL. Effect of different sample preparation methods on the results of the impedance technique in the study of platelet hyper-and hypo-function in whole blood. Thromb Res 1993;71:89.
13. Armstrong R, May JA, Losche W, Heptinstall S. Factors that contribute to spontaneous platelet aggregation and streptokinase-induced aggregation in whole blood. Thromb Haemost 1995;73:297.
14. Chant C, Fagan SC, Aurora SK, et al. Effects of aspirin on platelet aggregation in smokers and nonsmokers. Ann Pharmacother 1997;31:290.
15. Salmon DM. Optimisation of platelet aggregometry utilising microtitreplate technology and integrated software. Thromb Res 1996;84:213.